“Teva has decided not to renew its membership with PhRMA in 2023,” PhRMA spokesperson Brian Newell told Becker’s. “Our organization will remain focused on fighting for solutions that lower costs for patients at the pharmacy and protect the development of new cures and treatments.”
In response to questions about its exit, a Teva spokesperson told Becker’s the Israel-based company “annually review[s] effectiveness and value of engagements, consultants and memberships to ensure our investments are properly seated.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
